InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Browse the full record of transactions filed by Kalali Amir H, 董事. Director active across 2 companies, notably ATAI Life Sciences N.V.. Cumulatively, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €59k. Activity tracked since 22 June 2021. The latest transaction was filed on 22 June 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Amir H. Kalali is a Board Member at ATAI Life Sciences N.V. He plays a crucial role in the governance of the company, providing strategic advice and overseeing research and development initiatives. His expertise is essential for innovation in the life sciences sector.